ES376528A1 - Benzodiazepine derivatives and manufacture thereof - Google Patents
Benzodiazepine derivatives and manufacture thereofInfo
- Publication number
- ES376528A1 ES376528A1 ES376528A ES376528A ES376528A1 ES 376528 A1 ES376528 A1 ES 376528A1 ES 376528 A ES376528 A ES 376528A ES 376528 A ES376528 A ES 376528A ES 376528 A1 ES376528 A1 ES 376528A1
- Authority
- ES
- Spain
- Prior art keywords
- compound
- signifies
- same meaning
- general formula
- well
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Procedure for the preparation of benzodiazepine derivatives of the general formula **(See formula)** in which R1 means halogen or nitro; R2 signifies phenyl, halophenyl or pyridyl; R3 signifies hydrogen, alkyl, hydroxyalkyl, acyloxyalkyl, haloalkyl, monoalkylaminoalkyl, dialkylaminoalkyl or carboalkoxy; R4 signifies alkoxy, haloalkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, hydroxyalkyloxy, alkoxyalkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl; R5 signifies hydrogen or hydroxyl; and R6 signifies hydrogen or carboalkoxy; and in the case that R5 means hydrogen, the nitrogen atom in position 4 can carry an oxygen atom, and of the salts of these compounds, characterized by: a) reacting a compound of the general formula **(See formula)** where R1, R2 and R6 have the same meaning as before, or a respective 4-oxide, with a compound of the general formula **(See formula)** where stands for hydrogen, alkyl, haloalkyl, carboalkoxy or acyloxyalkyl; R8 signifies alkoxy, haloalkoxy, alkylthio or alkoxyalkylthio; and X stands for halogen, O well b) reacting a compound of the general formula **(See formula)** where R1 and R2 have the same meaning as before, with a vinyl ether of the general formula CH2 = CH-O-R9 V where R9 signifies alkyl; O well **(See formula)** where R1, R2 and R5 have the same meaning as before, R10 signifies hydrogen, alkyl, hydroxyalkyl, haloalkyl, monoalkylaminoalkyl, dialkylaminoalkyl or acyloxyalkyl; and R11 has the same meaning as explained for R4, but one at least of the R10 and R11 substituents means a monohaloalkyl or monohaloalkoxylic group and, in the case that R5 signifies hydrogen, the nitrogen atom in position 4 can carry an oxygen atom, with a monoalkylamine or dialkylamine; O well d) alkylating a compound of the general formula **(See formula)** where R1 and R2 have the same meaning as before; R12 signifies alkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, alkoxyalkoxy, alkylthio or aminoalkoxy; R13 signifies hydrogen, alkyl, monoalkylaminoalkyl, dialkylaminoalkyl or aminoalkyl, but one of at least one of the substituents R12 and R13 signifies an aminoalkoxy, monoalkylaminoalkoxy, aminoalkyl or monoalkylaminoalkyl group, or a respective 4-oxide; O well **(See formula)** where R1 and R2 have the same meaning as before; R14 signifies alkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, alkoxyalkoxy, alkylthio or a protected monoalkylaminoalkoxy group; and R15 means hydrogen, alkyl, monoalkylaminoalkyl, dialkylaminoalkyl, acyloxyalkyl or a protected monoalkylaminoalkyl group, but one of at least one of the R14 substituents, and R15 means a protected monoalkylaminoalkoxy or monoalkylaminoalkyl group, or of a respective 4-oxide, the protecting group; O well f) in a compound of the general formula **(See formula)** where R1, R2, R5 and R6 have the same meaning as before, but also, in the case of R5 meaning hydrogen, the nitrogen atom in position 4 can carry an oxygen atom; R16 stands for alkoxy, monohaloalkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, hydroxyalkoxy, alkoxyalkoxy, or alkylthio; and R17 stands for hydrogen, alkyl, hydroxyalkyl, monohaloalkyl, carboalkoxy, monoalkylaminoalkyl, dialkylaminoalkyl or acyloxyalkyl, but one at least of R16 and R17 substituents means monohaloalkoxy or monohaloalkyl, replacing aliphatically linked halogen atoms with hydroxy groups; O well g) in a compound of the general formula **(See formula)** where R1, R2, R5 and R6 have the same meaning as before; R18 signifies alkylthio; and R19 means hydrogen, alkyl, hydroxyalkyl, haloalkyl, carboalkoxy or acyloxyalkyl, but in case R5 means hydrogen, the nitrogen atom in position 4 can carry an oxygen atom, oxidize the alkylthio group converting it into an alkylsulfinyl or alkylsulfonyl group ; O well h) cyclizing a compound of the general formula **(See formula)** where R1, R2, R3, R4 and R6 have the same meaning as before; O well i) hydrolyzing a compound of the general formula **(See formula)** where R1, R2, R3, R4 and R6 have the same meaning as before, while R20 signifies an acyl group; O well j) deoxygenate a compound of the general formula **(See formula)** where R1, R2, R3 and R6 have the same meaning as before, while R21 stands for alkoxy, haloalkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, hydroxyalkoxy, alkoxyalkoxy or alkylthio; O well k) dehydrating a compound of the general formula **(See formula)** where R1, R2 and R6 have the same meaning as before; R22 stands for alkoxy, dialkylaminoalkoxy, alkoxyalkoxy or alkylthio; and R23 signifies hydrogen, alkyl, carboalkoxy, dialkylaminoalkyl or acyloxyalkyl; O well l) oxidizing or dehydrogenating at the 4,5 link a compound of the general formula **(See formula)** where R1, R2 and R6 have the same meaning as before; R24 signifies alkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, hydroxyalkoxy or alkoxyalkoxy; and R25 signifies hydrogen, alkyl, hydroxyalkyl, carboalkoxy, monoalkylaminoalkyl, dialkylaminoalkyl or acyloxyalkyl; O well m) saponifying and decarboxylating a compound of the general formula **(See formula)** where R1, R2, R4 and R5 have the same meaning as before; R26 means alkyl, R27 signifies hydrogen, alkyl, hydroxyalkyl, haloalkyl, monoalkylaminoalkyl, dialkylaminoalkyl or acyloxyalkyl; and in the case that R5 means hydrogen, the nitrogen atom in position 4 can carry an oxygen atom; O well n) oxidizing a compound of the general formula **(See formula)** where R1, R2, R3, R4 and R26 have the same meaning as before, to convert it to the 3-hydroxy compound; O well o) make it a compound of the general formula **(See formula)** where R1, R2, R6 and R25 have the same meaning as before, R28 means acyl; and R29 means alkoxy, monoalkylaminoalkoxy, dialkylaminoalkoxy, hydroxyalkoxy, alkoxyalkoxy or alkylthio, with a base, in the respective compound 4,5 dehydro; O well p) become a compound of the general formula **(See formula)** where R1, R2 and R6 have the same meaning as before; R30 signifies a mesyl or tosylic group; R31 signifies hydrogen, alkyl, hydroxyalkyl, carboalkoxy, dialkylaminoalkyl or acyloxyalkyl; and R32 signifies alkoxy, dialkylaminoalkoxy, hydroxyalkoxy, alkoxyalkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl, with a strong base, in the respective 4,5-dehydro compound; O well q) rearranging a compound of the general formula **(See formula)** where R1, R2, R3, R4 and R6 have the same meaning as before, converting it into the respective 4,5-dehydro compound; O well r) treating a compound of the general formula where R1, R2 and R6 have the same meaning as before, R40 represents hydroxyalkyl and R41 represents alkoxy, haloalkoxy, dialkylaminoalkoxy, alkoxyalkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl, or a respective 4-oxide, with an acylating agent; O well s) in a compound of the general formula **(See formula)** where R1, R2 and R6 have the same meaning as before, R42 represents haloalkyl and R43 represents alkoxy, dialkylaminoalkoxy, alkoxyalkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl, or a respective 4-oxide, converting the aliphatically linked halogen atom to an acyloxylic group; and/or t) if desired, converting a resulting compound to a salt. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH225569A CH562220A5 (en) | 1969-02-14 | 1969-02-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES376528A1 true ES376528A1 (en) | 1972-04-16 |
Family
ID=4229492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES376528A Expired ES376528A1 (en) | 1969-02-14 | 1970-02-13 | Benzodiazepine derivatives and manufacture thereof |
Country Status (23)
Country | Link |
---|---|
AT (10) | AT302322B (en) |
BE (1) | BE745852A (en) |
BR (1) | BR6915093D0 (en) |
CA (1) | CA971960A (en) |
CH (1) | CH562220A5 (en) |
CS (1) | CS159260B2 (en) |
DE (1) | DE2005508A1 (en) |
DK (1) | DK137899B (en) |
DO (1) | DOP1970001703A (en) |
ES (1) | ES376528A1 (en) |
FI (1) | FI49965C (en) |
FR (1) | FR2034550B1 (en) |
GB (5) | GB1306454A (en) |
IE (2) | IE33988B1 (en) |
IL (2) | IL33821A (en) |
IS (1) | IS1906A7 (en) |
NL (1) | NL156401B (en) |
NO (2) | NO128328B (en) |
OA (1) | OA03435A (en) |
PL (1) | PL80826B1 (en) |
RO (5) | RO57030A (en) |
SE (1) | SE358393B (en) |
SU (11) | SU402219A3 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE787117A (en) * | 1971-08-04 | 1973-02-05 | Hoffmann La Roche | BENZODIAZEPINE DERIVATIVES |
JPS4867288A (en) * | 1971-12-14 | 1973-09-13 | ||
US3932637A (en) * | 1974-07-22 | 1976-01-13 | Sumitomo Chemical Company, Limited | Methods and compositions for improving the feed intake of meat producing animals |
CA1163266A (en) * | 1980-07-31 | 1984-03-06 | Albert E. Fischli | Benzodiazepine derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3136815A (en) * | 1959-12-10 | 1964-06-09 | Hoffmann La Roche | Amino substituted benzophenone oximes and derivatives thereof |
-
1969
- 1969-02-14 CH CH225569A patent/CH562220A5/xx not_active IP Right Cessation
- 1969-12-15 BR BR215093/69A patent/BR6915093D0/en unknown
-
1970
- 1970-02-02 IL IL33821A patent/IL33821A/en unknown
- 1970-02-04 CA CA073,934A patent/CA971960A/en not_active Expired
- 1970-02-05 OA OA53847A patent/OA03435A/en unknown
- 1970-02-06 IE IE156/70A patent/IE33988B1/en unknown
- 1970-02-06 IE IE618/73A patent/IE33991B1/en unknown
- 1970-02-06 DE DE19702005508 patent/DE2005508A1/en not_active Ceased
- 1970-02-10 SU SU1691944A patent/SU402219A3/ru active
- 1970-02-10 SU SU1691947A patent/SU406360A3/ru active
- 1970-02-10 SU SU1666627A patent/SU428603A3/en active
- 1970-02-10 SU SU1658463A patent/SU406359A3/ru active
- 1970-02-10 SU SU1400104A patent/SU497774A3/en active
- 1970-02-10 SU SU1691526A patent/SU421195A3/en active
- 1970-02-10 SU SU1665719A patent/SU431673A3/ru active
- 1970-02-10 SU SU1691948A patent/SU453841A3/en active
- 1970-02-10 SU SU1691943A patent/SU404253A3/ru active
- 1970-02-10 SU SU1691525A patent/SU415880A3/en active
- 1970-02-11 GB GB6675372A patent/GB1306454A/en not_active Expired
- 1970-02-11 GB GB4314272A patent/GB1306455A/en not_active Expired
- 1970-02-11 GB GB3375172A patent/GB1306452A/en not_active Expired
- 1970-02-11 CS CS95470*#A patent/CS159260B2/cs unknown
- 1970-02-11 GB GB645070A patent/GB1306451A/en not_active Expired
- 1970-02-12 BE BE745852D patent/BE745852A/en unknown
- 1970-02-12 IS IS1906A patent/IS1906A7/en unknown
- 1970-02-12 DO DO1970001703A patent/DOP1970001703A/en unknown
- 1970-02-13 AT AT505671A patent/AT302322B/en not_active IP Right Cessation
- 1970-02-13 AT AT505771A patent/AT302323B/en not_active IP Right Cessation
- 1970-02-13 AT AT131770A patent/AT299208B/en not_active IP Right Cessation
- 1970-02-13 AT AT505171A patent/AT302317B/en not_active IP Right Cessation
- 1970-02-13 SE SE01893/70A patent/SE358393B/xx unknown
- 1970-02-13 PL PL1970138780A patent/PL80826B1/en unknown
- 1970-02-13 NL NL7002084.A patent/NL156401B/en not_active IP Right Cessation
- 1970-02-13 NO NO00510/70A patent/NO128328B/no unknown
- 1970-02-13 AT AT505371A patent/AT302319B/en not_active IP Right Cessation
- 1970-02-13 FR FR707005175A patent/FR2034550B1/fr not_active Expired
- 1970-02-13 ES ES376528A patent/ES376528A1/en not_active Expired
- 1970-02-13 AT AT505471A patent/AT302320B/en not_active IP Right Cessation
- 1970-02-13 AT AT505071A patent/AT301555B/en not_active Expired
- 1970-02-13 AT AT505571A patent/AT302321B/en not_active IP Right Cessation
- 1970-02-13 AT AT505271A patent/AT302318B/en not_active IP Right Cessation
- 1970-02-13 FI FI700400A patent/FI49965C/en active
- 1970-02-13 DK DK72870AA patent/DK137899B/en not_active Application Discontinuation
- 1970-02-13 AT AT504971A patent/AT302316B/en not_active IP Right Cessation
- 1970-02-14 RO RO68268A patent/RO57030A/ro unknown
- 1970-02-14 RO RO68266A patent/RO57160A/ro unknown
- 1970-02-14 RO RO68267A patent/RO57028A/ro unknown
- 1970-02-14 RO RO62467A patent/RO58075A/ro unknown
- 1970-02-14 RO RO68269A patent/RO57161A/ro unknown
- 1970-05-12 GB GB3385272A patent/GB1306453A/en not_active Expired
-
1971
- 1971-05-13 SU SU1657960A patent/SU517258A3/en active
-
1973
- 1973-01-24 NO NO00292/73A patent/NO128110B/no unknown
- 1973-05-22 IL IL7342330A patent/IL42330A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO954072L (en) | Water-soluble camptothecin derivatives, processes for their preparation and their use as antitumor agents | |
AR013358A1 (en) | COMPOUNDS DERIVED FROM EPOTILONE (DERIVATIVES FROM AZA CICLOHEXADECANO), USEFUL IN THERAPEUTICS. | |
ES433835A1 (en) | Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives | |
NO159172C (en) | NEW N-ALKYL NORSCOPINS. | |
SE7602122L (en) | NEW PIPERAZINYLIMINORIFAMYCINS AND WAYS TO PRODUCE THE SAME | |
SE7509861L (en) | PROCEDURE FOR THE PREPARATION OF N-ACYLAMINO-ALFA-ARYLACETAMIDO-CEPHALOSPORINES | |
GB1503077A (en) | Quaternary imidazolium compounds and their use as microbicides | |
ES376528A1 (en) | Benzodiazepine derivatives and manufacture thereof | |
ES411380A1 (en) | Pyrazoline compounds having insecticidal activity | |
ES278111A1 (en) | A procedure for the manufacture of replaced hydrazine derivatives (Machine-translation by Google Translate, not legally binding) | |
ES457872A1 (en) | 2-methoxy-benzamide derivatives | |
ES462305A1 (en) | Substituted 4-phenylurazoles and their use in agricultural fungicide compositions | |
GB1104773A (en) | Process for the preparation of 5-substituted oxazolidones-(2) | |
DE3569528D1 (en) | Penem derivatives, methods of producing them, their use and pharmaceutical compositions | |
EP0028936A3 (en) | 4-carbamoylimidazol-5-ol derivatives, their production and pharmaceutical compositions containing them | |
ES404744A1 (en) | Cephalosporin derivatives | |
ES378467A1 (en) | Novel aminopiperidines, processes for their preparation, and compositions incorporating them | |
ES451466A1 (en) | 5-thiazole-methane-amines, and their use as antilipolytics | |
ES315051A1 (en) | Method for the preparation of derivatives of natural isoflavones. (Machine-translation by Google Translate, not legally binding) | |
ES316314A1 (en) | Procedure for the production of derivatives of podofilotoxina. (Machine-translation by Google Translate, not legally binding) | |
ATE91033T1 (en) | PHOTOCHROMIC COMPOSITION AND ARTICLES CONTAINING SUCH COMPOSITION. | |
ES442441A1 (en) | 1,4-Oxathiino{8 2,3-c{9 pyrrole derivatives | |
ES306852A1 (en) | Improvements introduced in the preparation of herbicidal compositions. (Machine-translation by Google Translate, not legally binding) | |
ES418331A1 (en) | Quinoline derivatives processes for their preparation and compo sitions incorporating them | |
KR830007634A (en) | Preparation of N-pyrrolyl pyridazineamine |